Ellume to make more over-the-counter COVID-19 tests for and in U.S.
The Department of Defense today awarded Ellume USA $231.8 million to ramp up domestic production of its COVID-19 diagnostic test, the first test users can perform fully at home without a prescription. The agency expects the contract to increase daily domestic production of the test by 640,000 by December.
The contract also will procure 8.5 million of the tests for U.S. distribution. The Food and Drug Administration recently authorized emergency use of the test, which can detect the SARS-CoV-2 virus in a nasal swab sample and report the results via a smartphone app.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…